CBL and tauopathy: In the latter, SUVRVer/Cbl did not show a significant difference between the 3/4R-tauopathies and 4R-tauopathies, despite previous studies strongly indicating that [18F]PI-2620 could differentiate between these two disease entities [10, 11].